Wellington Biomedical Innovation Investors (cayman) II L.P.
Private Equity FundFund ID 805-6623751456Cayman Islands
Gross assets
$171.9M
Min. investment
$1M
Beneficial owners
29
Size rank
Top 34%
Audited
Yes
Structure
Feeder
About this fund
Wellington Biomedical Innovation Investors (cayman) II L.P. is a private equity fund managed by Wellington Alternative Investments LLC. The fund reports $171.9 million in gross assets, placing it among the top 34% of private funds by size. The stated minimum investment is $1 million. Its financial statements are audited annually. Private funds are not required to publicly disclose returns; Form ADV reports assets, structure, and service providers, shown above.
Fund details
| Fund ID | 805-6623751456 |
| Fund type | Private Equity Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | Yes |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 100% |
Other funds from this manager
| Fund | Type | Gross assets |
|---|---|---|
| Global Research Equity Extended Master Fund (cayman), L.P. | Hedge | $18.23B |
| US Research Equity Extended Master Fund (cayman) L.P. | Hedge | $11.31B |
| Wellington Macro Strategies Master Fund (cayman) L.P. | Hedge | $9.2B |
See all 124 funds from this manager — unlock the full record.
Join to unlock · $37/moFrequently asked questions
How large is Wellington Biomedical Innovation Investors (cayman) II L.P.?
Wellington Biomedical Innovation Investors (cayman) II L.P. reports $171.9 million in gross assets, among the top 34% of private funds by size.
What is the minimum investment for Wellington Biomedical Innovation Investors (cayman) II L.P.?
The stated minimum investment is $1 million.
Who manages Wellington Biomedical Innovation Investors (cayman) II L.P.?
Wellington Biomedical Innovation Investors (cayman) II L.P. is managed by Wellington Alternative Investments LLC.
Does Wellington Biomedical Innovation Investors (cayman) II L.P. disclose returns?
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.
Manager
W
Boston, MA
Service providers
Prime broker
None reported
Custodian
Administrator
Auditor
Marketer
Reported gross assets
$171.9M▲ 2%
Jan '25Form ADV, monthlyJun '26
How this fund compares
Gross assetsTop 34%
Larger than 66% of 67,041 private funds
Gross assets vs Private Equity FundsTop 30%
Larger than 70% of 31,066 private equity funds
Minimum investmentTop 33%
Higher than 67% of funds reporting a minimum
Investor base
Adviser & related persons1%
Funds of funds45%
Non-U.S. persons69%
Share of the fund's beneficial ownership reported on Form ADV. Categories can overlap.